INTEGRATED RESULTS OF TWO MULTICENTER, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND, PHASE 3 TRIALS (SPI-611/612) OF SINGLE-DOSE INTRAVESICAL APAZIQUONE IMMEDIATELY FOLLOWING RESECTION IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER Meeting Abstract

cited authors

  • Karsh, Lawrence; Shore, Co Neal; Beach, Myrtle; Saltzstein, Daniel; Bhat, Gajanan; Reddy, Guru; Allen, Lee F.; Soloway, Mark

Publication Date

  • April 1, 2016

webpage

published in

category

start page

  • E290

end page

  • E290

volume

  • 195

issue

  • 4